These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3736637)

  • 1. Increase in bone mass after treatment of hyperprolactinemic amenorrhea.
    Klibanski A; Greenspan SL
    N Engl J Med; 1986 Aug; 315(9):542-6. PubMed ID: 3736637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of prolactin and estrogen deficiency in amenorrheic bone loss.
    Klibanski A; Biller BM; Rosenthal DI; Schoenfeld DA; Saxe V
    J Clin Endocrinol Metab; 1988 Jul; 67(1):124-30. PubMed ID: 3379129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A longitudinal analysis of premenopausal bone loss in healthy women and women with hyperprolactinemia.
    Schlechte J; Walkner L; Kathol M
    J Clin Endocrinol Metab; 1992 Sep; 75(3):698-703. PubMed ID: 1517357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea.
    Biller BM; Baum HB; Rosenthal DI; Saxe VC; Charpie PM; Klibanski A
    J Clin Endocrinol Metab; 1992 Sep; 75(3):692-7. PubMed ID: 1517356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone density in amenorrheic women with and without hyperprolactinemia.
    Schlechte JA; Sherman B; Martin R
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1120-3. PubMed ID: 6404918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forearm and vertebral bone mineral in treated and untreated hyperprolactinemic amenorrhea.
    Schlechte J; el-Khoury G; Kathol M; Walkner L
    J Clin Endocrinol Metab; 1987 May; 64(5):1021-6. PubMed ID: 3558723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mineral content of amenorrheic and eumenorrheic athletes.
    Drinkwater BL; Nilson K; Chesnut CH; Bremner WJ; Shainholtz S; Southworth MB
    N Engl J Med; 1984 Aug; 311(5):277-81. PubMed ID: 6738640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vertebral body bone mineral content in hyperprolactinemic women.
    Koppelman MC; Kurtz DW; Morrish KA; Bou E; Susser JK; Shapiro JR; Loriaux DL
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1050-3. PubMed ID: 6490793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study on bone metabolism in woman with hyperprolactinemia].
    Fujimaki T; Kurabayashi T; Ootani T; Yamamoto Y; Yasuda M; Tanaka K
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 May; 46(5):423-8. PubMed ID: 8182302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlations between hyperprolactinemia and galactorrhea].
    Romero Gutierrez G; Aguirre Beltran AF; Figueroa Solana MI; Malacara Hernandez JM
    Ginecol Obstet Mex; 1989 Nov; 57():294-7. PubMed ID: 2486966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma calcitonin, IGF-I levels and vertebral bone mineral density in hyperprolactinemic women during bromocriptine treatment.
    Tørring O; Isberg B; Sjöberg HE; Bucht E; Hulting AL
    Acta Endocrinol (Copenh); 1993 May; 128(5):423-7. PubMed ID: 8317189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catecholamines and pituitary-function. V. Effect of low-dose dopamine infusion on basal and gonadotropin-releasing hormone stimulated gonadotropin release in normal cycling women and patients with hyperprolactinemic amenorrhea.
    Nicoletti I; Ambrosi F; Giammartino C; Fedeli L; Mannarelli C; Filipponi P
    Horm Metab Res; 1986 Jul; 18(7):479-84. PubMed ID: 3091473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral content of the hyperprolactinemic rat femur by single photon absorptiometry.
    Fiore CE; Clementi G; Prato A; Foti R; Conforto G
    Horm Metab Res; 1988 Jan; 20(1):40-3. PubMed ID: 3371856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoporosis in men with hyperprolactinemic hypogonadism.
    Greenspan SL; Neer RM; Ridgway EC; Klibanski A
    Ann Intern Med; 1986 Jun; 104(6):777-82. PubMed ID: 3706929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catecholamines and pituitary function. VII: Effects of acute and chronic dopamine-receptor blockade on pituitary response to TRH-GNRH in normal women and in patients with hyperprolactinemic amenorrhea.
    Giammartino C; Ambrosi F; Pelicci G; Pagliacci MC; Fedeli L; Nicoletti I
    Horm Metab Res; 1988 Jan; 20(1):44-8. PubMed ID: 3131222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers of bone turnover and bone mineral density in hyperprolactinemic amenorrheic women.
    Shaarawy M; El-Dawakhly AS; Mosaad M; El-Sadek MM
    Clin Chem Lab Med; 1999 Apr; 37(4):433-8. PubMed ID: 10369115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of bone accretion and amenorrhea: evidence for a relative osteopenia in weight-bearing bones.
    Warren MP; Brooks-Gunn J; Fox RP; Lancelot C; Newman D; Hamilton WG
    J Clin Endocrinol Metab; 1991 Apr; 72(4):847-53. PubMed ID: 2005212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoporosis and amenorrhea in young women.
    Glazener CM; Sargood AJ; Jackson PC; Staddon GE; Bryan GJ; Davies ER; Hartog M; Hull MG
    Gynecol Endocrinol; 1987 Sep; 1(3):255-61. PubMed ID: 3503484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of bone mineral density in amenorrheic women with dual photon absorptiometry.
    Soong YK; Hsu JJ; Tzen KY
    Taiwan Yi Xue Hui Za Zhi; 1989; 88(11-12):1097-103. PubMed ID: 2636246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of bone density in amenorrheic women due to athletics, weight loss, and premature menopause.
    Jones KP; Ravnikar VA; Tulchinsky D; Schiff I
    Obstet Gynecol; 1985 Jul; 66(1):5-8. PubMed ID: 4011070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.